Astrana Health
ASTH
154 hedge funds and large institutions have $772M invested in Astrana Health in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 37 reducing their positions, and 9 closing their positions.
408% more call options, than puts
Call options by funds: $8.09M | Put options by funds: $1.59M
222% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 9
76% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 37
15% more funds holding
Funds holding: 134 → 154 (+20)
8% more capital invested
Capital invested by funds: $718M → $772M (+$54.4M)
3.98% more ownership
Funds ownership: 39.73% → 43.71% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
3C
325 Capital
New York
|
+$16.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12M |
| 3 |
BlackRock
New York
|
+$10.1M |
| 4 |
Morgan Stanley
New York
|
+$7.05M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.81M |
| 2 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$1.19M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$977K |
| 4 |
Two Sigma Advisers
New York
|
-$833K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$813K |
ASTH Hedge Fund Activity: Q3 2022 in Review
154 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2022, worth a combined $772M — up 7.6% from $718M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ASTH positions and 9 closed out — a net gain of 20 holders — while 65 added to existing stakes and 37 trimmed.
The largest buyer was 325 Capital, opening a new position worth an estimated $16.4M. The largest seller was Millennium Management, cutting an estimated $1.81M.
- 154 institutional investors held Astrana Health (ASTH) as of Q3 2022, up from 134 in Q2 2022.
- Funds reported $772M of Astrana Health stock for Q3 2022, up 7.6% quarter-over-quarter.
- 29 funds opened new Astrana Health positions in Q3 2022 and 9 closed out, a net change of +20 holders.
- The largest Astrana Health buyer in Q3 2022 was 325 Capital, an estimated $16.4M added.
- The largest Astrana Health seller in Q3 2022 was Millennium Management, an estimated $1.81M sold.
Based on aggregated 13F filings for Q3 2022.